DG Peptide Protocols
EmergingSexual Health

Kisspeptin

KP-10

KISS1 Gene Product | Reproductive Neuropeptide

Half-life
~4 minutes (KP-10), ~28-32 minutes (KP-54)
Chain length
10–54 amino acids (variant-dependent)
Reference frequency
Single dose for testing, or 2-3 times weekly (NEVER daily - causes desensitization)

Research overview

DoseGear research brief

Kisspeptin acts as a master regulator of the reproductive system, stimulating GnRH neurons essential for puberty, fertility, and reproductive function.

Mechanism of action

Binds to GPR54/KISS1R receptors on hypothalamic GnRH neurons, triggering pulsatile GnRH release, which stimulates pituitary LH/FSH secretion and gonadal steroid production.

Compound background

Development & research timeline

Study windows describe what researchers measured, not when an individual should expect a result.

Origin & development

Endogenous KISS1-derived peptide family.

What it is researched for

Reproductive-axis, fertility, and sexual-response research through KISS1R activation and hypothalamic GnRH signaling.

Research observation window

Not reported in the reviewed compound-specific evidence. Formulation stability is not an effects timeline.

Reference data

Lyophilized vial injectable protocols

Not personalized dosing instructions

Only injectable vial references are shown. Nasal, topical, and unsupported non-vial schedules are excluded.

Research contextAmountFrequencyRoute
Gonadotropin stimulation100-200mcgSingle dose or 2-3x weeklySubQ
Fertility support0.4-1.0 nmol/kg (50-150mcg)As directed by physicianSubQ (KP-54)
Sexual function (clinical)1 nmol/kg/h75-minute IV infusionIV infusion

Reference cycle

2-4 weeks

Reference storage

Lyophilized: Room temperature; Reconstituted: 2-8°C; KP-10: use within 7 days; KP-54: use within 14 days

Safety context

Reported side effects

  • Minimal acute side effects reported
  • Potential mild cardiovascular effects

Contraindications & cautions

  • Not recommended during pregnancy or breastfeeding
  • Caution with cardiovascular disease history
  • Daily dosing causes receptor desensitization

Scientific references

  1. 01

    Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial

    Scientific citationEffects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial. JAMA Network Open (2023).
  2. 02

    Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial

    Scientific citationEffects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial. JAMA Network Open (2022).
  3. 03

    Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of OHSS During IVF Therapy

    Scientific citationEfficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of OHSS During IVF Therapy. Journal of Clinical Endocrinology & Metabolism (2015).
  4. 04

    Intranasal Kisspeptin Administration Rapidly Stimulates Gonadotropin Release in Humans

    Scientific citationIntranasal Kisspeptin Administration Rapidly Stimulates Gonadotropin Release in Humans. eBioMedicine (2025).

This DoseGear profile combines published scientific literature with lyophilized-vial protocol references. Citations are provided for independent review.

Related research profiles